OncoSpherix Revenue

Biotechnology Research • Atlanta, Georgia, United States • 1-10 Employees

OncoSpherix revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	$2,000,000

Key Contact at OncoSpherix

Steve Coats

Vice President of Chemistry

Company overview

Headquarters	Atlanta, Georgia, United States
Website	oncospherix.com
NAICS	541714
SIC	738
Founded	2018
Employees	1-10
Socials

OncoSpherix Email Formats

OncoSpherix uses 1 email format. The most common is {last name} (e.g., doe@oncospherix.com), used 100% of the time.

Format	Example	Percentage
{last name}	doe@oncospherix.com	100%

About OncoSpherix

OncoSpherix, Inc., based in Atlanta, Ga, is a pre-clinical stage oncology drug development company that is advancing a proprietary platform of first-in-class small molecule therapeutics that are designed to improve the quality of life and survival for people with many forms of cancer by targeting a common feature of solid tumors: the activation of hypoxia inducible factor-1 (HIF-1). Nearly all solid cancers grow faster than their blood supply, leading to regions of low oxygen in the tumors and HIF activation. The HIFs in turn induce the expression of over 100 genes that help tumor cells survive and spread. OncoSpherix has several classes of small molecules that block activation of HIF-1 through novel mechanisms. OncoSpherix’s lead clinical candiate has been shown in mouse models to reduce primary tumor growth, inhibit metastases, and prolong survival in many types of cancer (glioblastoma, pancreatic cancer, uveal melanoma, lung cancer, breast cancer). Importantly, the agents are well tolerated and can be combined with therapeutics that work in well oxygenated regions of cancers, leading to dramatically enhanced cancer control.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

Entry

Partner

Employees by Department

OncoSpherix has 3 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore OncoSpherix's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-05-01	9	$2,000,000

Funding Insights

$2,000,000

Total funding amount

$2,000,000

Most recent funding amount

Number of funding rounds

OncoSpherix Tech Stack

Discover the technologies and tools that power OncoSpherix's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

jQuery

JavaScript libraries

Nginx

Reverse proxies

PHP

Programming languages

Bluehost

Hosting

WordPress

Blogs

Divi

Page builders

MySQL

Databases

RSS

Miscellaneous

Priority Hints

Performance

Google Font API

Font scripts

jQuery Migrate

JavaScript libraries

Frequently asked questions

OncoSpherix is located in Atlanta, Georgia, US.

OncoSpherix generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

OncoSpherix has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

OncoSpherix was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

OncoSpherix has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

OncoSpherix has raised a total of $2,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at OncoSpherix

Steve Coats

Vice President of Chemistry

4.8

40,000 users